Showing results (121-130 of 205) with videos related to
Sort By:
Pageof 21
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2014
Cost-effectiveness of a computerized provider order entry system in improving medication safety ambulatory careSara H Forrester, Zsolt Hepp, Joshua A Roth, et al.Journal of Evaluation in Clinical Practice|October 21, 2016
A proposed approach for quantitative benefit-risk assessment in diagnostic radiology guideline development: the American College of Radiology Appropriateness Criteria ExampleMaria Agapova, Brian B Bresnahan, Mitchell Higashi, et al.Journal of Managed Care & Specialty Pharmacy|December 30, 2020
Use of real-world evidence in economic assessments of pharmaceuticals in the United StatesWoojung Lee, Victoria Dayer, Boshen Jiao, et al.Drug and Alcohol Dependence|February 23, 2016
Preference weights for the spectrum of alcohol use in the U.S. PopulationLaura J Chavez, Katharine Bradley, Nathan Tefft, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2022
A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 2-Data From NonwearablesWoojung Lee, Naomi Schwartz, Aasthaa Bansal, et al.Academic Radiology|August 10, 2014
Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunitiesMaria Agapova, Emily Beth Devine, Brian W Bresnahan, et al.Journal of Managed Care & Specialty Pharmacy|January 28, 2021
Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorderJamie T Ta, Sean D Sullivan, Amy Tung, et al.Plos One|April 28, 2022
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell diseaseKate M Johnson, Boshen Jiao, M A Bender, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic ReviewBoshen Jiao, Anirban Basu, Scott Ramsey, et al.Expert Review of Pharmacoeconomics & Outcomes Research|April 1, 2022
A landscape analysis and discussion of value of gene therapies for sickle cell diseaseDalyna Quach, Boshen Jiao, Anirban Basu, et al.Pageof 21